Record precisely what a patient agreed to when their genetic data was collected, then test every downstream research query or third-party share against those terms. Consent stops being a signed form in a drawer and becomes an enforced, verifiable rule.
Turn a broad paper consent form into a granular, machine-checkable permission that governs each use.
01.
The DID and VC Ledger records the specific purposes a patient approved, research, insurer access, or lab sharing, as a signed credential rather than an open-ended waiver.
02.
The Compliance Attestations module checks each proposed use against the anchored terms, so a query outside the agreed scope is refused before any data is released.
03.
The Audit Logs module records every access and share, giving the patient and the regulator a complete, tamper-evident history of who used the data and why.
04.
A patient can revoke a purpose, and the gate immediately stops honoring queries under that purpose, without needing to trust each downstream party to comply.
05.
A research partner or insurer proves it holds a valid permission for a dataset before access, so unauthorized secondary use becomes structurally impossible.
06.
The patient sees exactly what was agreed and every use made of their genome, replacing a blind broad-consent form with a live, auditable record they control.
Follow one patient's genetic consent from signing through a scoped research query to a later withdrawal.
10:05:12
[SYS] Recording consent for subject DID:gen:5521...
10:05:12
[CMD] anchorConsent { research: true, insurer: false, share: false }
10:05:13
[AUTH] Signing consent credential to patient DID...
10:05:13
[OK] Consent anchored at block 6031877.
Cerulea decomposes genomic consent into modular contracts. Each layer anchors, gates, logs, and revokes permission so a patient's terms govern every use of their genome.
Enforceable genomic consent is a horizontal capability. Here is how different actors around genetic data put it to work.
Prove to patients and regulators that every use of a genome was covered by a specific, active consent, turning a sensitive data liability into a demonstrable compliance strength.
Key Asset Types
Access genomic datasets with cryptographic proof that each subject approved research use, removing the legal uncertainty that stalls multi-site studies and secondary analyses.
Key Asset Types
Audit how genetic data was used against the consent that governed it, replacing document requests and self-attestations with a live, tamper-evident usage history.
Key Asset Types
Whether you are bridging a laboratory data platform or capturing consent directly from a patient's device, Cerulea routes both into one enforceable consent record.
For genetic testing providers on existing data platforms. Access requests are checked against anchored consent through the API gateway before any dataset is released.
Lab Data Platform
Genomic Repository
Cerulea API Gateway
Consent Enforcement
Cerulea Private Chain
Consent & Usage Ledger
For patients on a personal wallet. Consent and withdrawals are signed from the patient's own device and routed directly to the ledger they control.
Patient App / Wallet
Subject Devices
Consortium Validators
Consent Consensus
Cerulea Ledger
Patient Consent Record
Building a granular consent ledger with a usage gate, immutable logging, and instant withdrawal from scratch requires specialised privacy engineers and long legal review cycles. Calculate your exact deployment speed using Cerulea.
Traditional Deployment
Solidity Coding & Audits
~ 13 Months
Visual Compilation
WASM Logical Artifacts
~ 4 Weeks
The legacy timeline reflects health-data privacy integration benchmarks. Building granular consent capture, a purpose-enforcing access gate, and tamper-evident usage logging for an average deployment takes a baseline of 9 months. Building the same architecture on Cerulea takes a baseline of 2 weeks, because Cerulea Studio visually translates your consent and usage rules into pre-audited WebAssembly binaries and provisions the consent and usage ledger instantly.